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ABSTRACT: 
 
Background: Isocyanates are one of the most commonly reported causes of occupational 
asthma; however, the risks of developing isocyanate asthma in modern production 
facilities remain poorly defined. The purpose of the present investigation was to evaluate 
TDI exposure and respiratory health among an inception cohort of workers during their 
first year of employment at a new polyurethane foam production factory. 
 
Methods: Forty-nine newly hired workers were evaluated pre-employment, 6-months, 
and 12-months post-employment through questionnaire, spirometry and TDI-specific 
serology. Airborne TDI levels were monitored by fixed-point air sampling and limited 
personal sampling. Qualitative surface SWYPE™ tests were performed to evaluate 
potential sources of skin exposure. 
 
Results: Airborne TDI levels were low; over 90% of fixed-point air measurements were 
below the limit of detection (0.1 ppb). Over the first year of employment, 12 of the 49 
original workers (24.5%) were lost to follow-up, no additional workers were enrolled, 
and seven of the 49 original workers (14.2%) developed either new asthma symptoms 
(N=3), TDI-specific IgG (N=1), new airflow obstruction (N=1) and/or a decline in FEV1 
≥ 15% (N=3), findings that could indicate TDI-related health effects. The prevalence of 
current asthma symptoms was significantly higher in the workers lost to follow-up 
compared to those who completed the study (25% vs 2.7%; p=0.04). 
 
  
 
 
Conclusions: The findings suggest possible early TDI-related health effects in a modern 
polyurethane production plant. These findings also highlight the need for further 
longitudinal evaluation of these workers and the challenges of studying workers at risk 
for isocyanate asthma. 
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INTRODUCTION: 
 
Isocyanates are highly reactive chemical compounds characterized by the presence of 
N=C=O groups widely used for the production of a variety of products including foams, 
adhesives, coating materials, and elastomers
1,2
. There are many different forms of 
isocyanates used in the various industries, of which the most commonly used are the 
monoisocyanate (one functional N=C=O group per molecule) methyl isocyanate (MIC) 
and the diisocyanates (two functional N=C=O groups per molecule) toluene diisocyanate 
(TDI), diphenyl-methane diisocyanate (MDI), hexamethane diisocyanate (HDI), and 
isophorone diisocyanate (IPDI)
2,3
. Previous studies have clearly shown that exposure to 
isocyanates may lead to occupational asthma
1
. 
 
Although isocyanates remain one of the most commonly reported causes of occupational 
asthma
4
, the prevalence, incidence, and risk factors for development of isocyanate asthma 
under current work conditions are not well defined, as there have been few recent 
epidemiology studies of isocyanate-exposed workers, despite the increasing use of 
polyurethane products in numerous industries
5
. More recent studies have largely been 
limited to cross-sectional studies of end-users such as spray painters, rather than factory 
workers producing polyurethane products
6,7
. Further, the majority of epidemiology 
studies of isocyanate-exposed workers, past or recent, have been cross-sectional in design, 
and prone to the healthy worker effect
8
. The few longitudinal studies have been 
conducted largely at primary isocyanate production facilities
9,10
, rather than secondary 
polyurethane production plants. 
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The present investigation of workers from a newly built modern TDI-based polyurethane 
foam factory in Eastern Europe provides a rare opportunity to evaluate the risk of TDI 
asthma among workers employing state-of-the-art polyurethane foam production 
technology. The factory is located in the city of Baia Mare in the Maramureş region of 
northwest Romania, approximately 600 kilometres away from the capital city of 
Bucharest, 70 kilometres away from the Hungarian border, and 50 kilometres away from 
the Ukrainian border. A prospective inception cohort study was initiated with the initial 
group of workers (N=49) employed at the plant. 
 
Respiratory health and TDI-specific IgG and IgE were assessed pre-employment, and 
reassessed along with exposure potential at 6-month intervals post-employment. Data 
from the initial 12-month study period showed that almost 25% of the initial workers 
were lost to follow-up and 14.2% had findings that could indicate risk for the 
development of isocyanate asthma. 
 
The data contained in the present investigation were obtained from January 2010 to 
January 2011 as an international collaborative research effort between investigators at the 
Yale University School of Medicine in the New Haven, Connecticut, United States and 
the Environmental Health Center in Cluj-Napoca, Romania. After careful compilation of 
the data, analysis and interpretation were subsequently undertaken and the final findings 
are presented in this report. The author of this Yale University School of Medicine thesis, 
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W.G., takes full responsibility for the contents and all efforts have been made to ensure 
the accuracy of the data. 
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SPECIFIC AIMS: 
 
1) To characterize TDI exposure, TDI sensitization, and TDI-health effects in a modern TDI 
polyurethane plant via air sampling monitoring, questionnaires, serum antibody 
immunoassays, and spirometry. 
2) To better understand the incidence and natural history of TDI sensitization and TDI-
induced occupational asthma (OA) through the longitudinal inception cohort study design. 
3) To apply the results from the study to reduce TDI exposures and the risk of TDI-
sensitization and related health effects. 
10 
 
 
 
HYPOTHESIS: 
 
Despite the presence of state of the art control measures to limit the exposure to 
isocyanates at the newly built, modern polyurethane production factory, opportunities for 
isocyanate exposure, sensitization and subsequent health effects in the workers may occur. 
 
11 
 
 
 
METHODS: 
 
Overall Study Design: 
 
The study was conducted at a newly built modern TDI polyurethane foam factory in 
Eastern Europe with an on-site health clinic. The entire initial production workforce 
(N=49) was recruited to participate in the study following a brief informational session, 
during which employees learned about the study and informed consent was obtained. 
Workers completed an interviewer-administered questionnaire, underwent spirometry 
testing, and provided peripheral blood for serology pre-employment and at 6 and 12 
months after employment. The human subjects study protocol was approved by oversight 
committees of the Human Investigations Committee (HIC) at Yale University, New 
Haven, Connecticut, United States, and the Institutional Review Board at Environmental 
Health Center, Cluj-Napoca, Romania. 
 
The HIC protocol was predominantly prepared and updated by Dr. Meredith Stowe at the 
Yale Occupational and Environmental Medicine Program. I provided input and 
recommendations where appropriate. 
 
Questionnaire: 
 
Pre-employment questionnaire: 
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A pre-employment questionnaire was created to gather baseline data regarding: a) 
demographics; b) respiratory health; c) smoking history; d) general health; e) 
employment history; f) personal protective equipment; g) ventilation at the workplace; h) 
cleaning at the workplace. 
 
This baseline questionnaire was developed by our colleagues at the Environmental Health 
Center in Romania based on previous experience with regional workplace populations 
and was implemented prior to employment for the workers.  
 
6-month follow-up questionnaire: 
 
Questionnaires were administered in an interview-based format. Workers were invited to 
the health clinic, as a private environment, for completion of the questionnaires. The 
workers were informed that their employers did not have any access to their confidential 
responses and were asked to answer each question truthfully.  If they did not have an 
answer to a question, they answered with the phrase “I Don’t Know”. Follow-up 
interviewer-administered questionnaires contained additional questions regarding skin 
exposure, use of personal protective equipment (PPE) and temporal relationships of 
respiratory symptoms to work. Asthma-like symptoms included at least one of the 
following: 1) cough, 2) wheeze, 3) chest tightness, and 4) shortness of breath, and were 
classified as work-related if they worsened while at work and improved while away from 
work. Possible TDI skin exposure was determined from the questionnaire by assessing 
13 
 
 
 
whether workers reported frequently touching or handling recently cured polyurethane 
foams. 
 
I was responsible for creating the follow-up questionnaire and providing directions for 
implementation. The questionnaire was administered by our colleagues in Romanian with 
consultation from our team at the Yale Occupational and Environmental Medicine 
Program. Once the gathering of data was complete, I compiled the data and performed 
the analyses. 
 
Spirometry Testing: 
 
Spirometry at 6 and 12 months was performed with the PC Portable Microlyser (P&A 
Medical Limited, Blackrod, UK) according to ATS/ERS Guidelines
11
, including proper 
calibration and a minimum of 3 acceptable spirograms. Due to logistical issues pre-
employment spirometry was performed on only 24 of the workers and at an alternate 
facility. 
 
The largest FVC and FEV1 from all acceptable curves were chosen and compared to 
predicted values and lower limit of normal (LLN), and airflow obstruction was defined as 
FEV1/FVC < LLN, as recommended by the ATS/ERS
12
. Excessive longitudinal decline 
in FEV1 over the follow-up period was identified using a threshold of 15% decline from 
baseline, as recommended by ATS and ACOEM
12,13
. 
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All of the spirometry testing was performed by our colleagues in Romania. Once the 
testing was complete, I compiled all of the spirometry data and performed the analyses of 
the data. 
 
Serology Testing: 
 
Venipuncture: 
Workers were invited to the health clinic at the factory site for venipuncture conducted by 
a trained and licensed laboratory nurse. The clinic was located in a building 
approximately 500 m away from the raw materials and manufacturing complex and was 
separated into three rooms: a) office and administrative duties room; b) exam and 
medicines room; c) venipuncture room. 
 
The venipuncture room had the approximate dimensions of 3 m x 4 m and contained a 
sink, a counter, and a few chairs. Each worker was asked to sit down on the chair and 
extend each arm for the nurse to examine. Once the arm with the vein deemed most 
suitable for venipuncture was chosen, the worker extended the chosen arm and rested the 
arm on top of the back of a chair. The nurse then applied an elastic band on the arm 
proximal to the site of venipuncture and asked the worker to make a fist with that arm. A 
BD Vacutainer SST Plus Blood Collection Tube (Becton, Dickenson and Company, 
Franklin Lakes, NJ) was attached to a standard phlebotomy needle and the worker’s 
superficial cubital fossa was wiped with a cotton swab covered with isopropyl alcohol. 
The needle was then inserted into a suitable vein in the superficial cubital fossa and the 
15 
 
 
 
Vacutainer Tube began to fill with blood. Before the tube fully filled with blood, the 
rubber band was released from the worker’s arm and the worker was asked to release the 
fist. When the tube was filled to approximately 10 mL of blood, the nurse released the 
tube from the needle. The needle was subsequently released and the cotton swab was 
applied to the place at which the needle was inserted. The blood was subsequently 
centrifuged at 400 x g and the serum fraction was aliquoted, and cryopreserved at -80°C. 
 
TDI-Specific Antibodies: 
TDI-specific IgG and IgE levels in serum samples from each worker at baseline, 6-, and 
12-months post-employment were measured using enzyme linked immunosorbent assays 
(ELISA)
14
. TDI-albumin conjugates (10 μg/ml) prepared by mixed phase (vapor/liquid) 
exposure methods were used to coat 96-well NUNC Maxisorp ELISA plates (Thermo 
Fisher Scientific Inc., Waltham, MA), followed by blocking with 3% dry milk in 
phosphate buffered saline (PBS). Workers’ sera were diluted in 3% milk + PBS + 0.05% 
Tween 20 and TDI-specific IgG was detected with horseradish peroxidase linked anti-
human IgG antibodies from Pharmingen (San Jose, CA), and expressed as an end-titer. 
For detecting TDI-specific IgE, plates were developed with biotinylated goat anti-human 
IgE (Bethyl; Montgomery, TX) followed by alkaline phosphatase conjugated streptavidin, 
and pNPP substrate from Thermo Fisher Scientific Inc. Plates were read using BioRad 
Model 550 Microplate Reader at dual wavelengths of 450 nm/550 nm for TDI-specific 
IgG assays and at 415 nm/550 nm for TDI-specific IgE assays. 
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The blood draws were completed by our colleagues in Romania and the antibody assays 
were performed by Jian Liu with direction from Dr. Wisnewski at the Yale Department 
of Internal Medicine. I was present in the laboratory for a significant portion of the assays. 
Once the results were available, I performed additional analyses. 
 
Exposure Assessment: 
 
Airborne exposure information from the factory’s foaming hall and cutting area was 
collected through continuous fixed-point air sampling with 18 minute sampling intervals 
using ChemLogic 1 direct reading instruments (DOD Technologies, Inc., Chrystal Lake, 
IL). Personal quantitative sampling was performed using flow pumps from Gilian 
(Sensidyne, LP, Clearwater, FL) and DuPont (E.I. du Pont de Nemours and Co., 
Wilmington, DE), which were calibrated before and after sampling to approximately 300 
cc/min. Personal breathing zone samples were collected at 0.3 L/minute flow for 20-30 
minutes on silica gel coated cartridges, and preserved at 4°C until analysis. TDI was 
extracted from cartridges by adding 2 mL methanol with shaking for two minutes. 
Following filtration, samples were analyzed by GC-MS (Shimadzu QP 2010 Plus; Kyoto, 
Japan), on an AT-502.2 capillary column, 60 m length, 0.32 mm diameter and 1.8 μm 
film thickness. Surface exposure was qualitatively assessed using colorimetric SWYPE™ 
wipes that develop color on contact with TDI, with depth of color roughly proportional to 
TDI concentration (Colormetric Laboratories, Inc., Des Plaines, IL)
15
. Skin exposure was 
similarly evaluated using the colorimetric SWYPE™ on a single foam line worker. 
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Workers’ Exposure Risk Groups: 
 
Workers were grouped with regard to their potential risk of TDI exposure (high, medium, 
low), based on their primary work location and duties, with the input of an industrial 
hygienist who had evaluated the plant. Workers who spent most of their time in the 
foaming hall, where foam was produced from raw materials including TDI were 
classified into the high exposure risk group; those who spent most of their time in the 
cutting area where foam blocks are cut to size after a period of curing, in the laboratory, 
where production samples are tested, and in maintenance were included in the medium 
exposure risk group, and the remaining workers, such as administrative, quality and 
warehouse, were included in the low exposure risk group. 
 
The exposure analyses were jointly performed by Judy Sparer and myself during our site 
visit to Romania and upon return to the Yale Occupational and Environmental Medicine 
Program. I was responsible for compiling the exposure data and for performing additional 
analyses. 
 
Statistical Analysis: 
 
Statistical analysis was performed using SAS (SAS Institute, Cary, NC). Summary 
descriptive statistics were calculated for baseline variable characteristics. Associations 
between categorical variables were tested using Fisher’s exact test, while continuous 
18 
 
 
 
variables were compared using generalized linear modeling. A p value < 0.05 was 
considered statistically significant. 
 
Statistical analyses were predominantly performed by Dr. Slade at the Yale Occupational 
and Environmental Medicine Program. However, I was present to answer questions and 
for consultation for the majority of the analyses performed. 
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RESULTS: 
 
Plant, Demographics and Workforce Exposure Risk Groups:  
 
The plant, a new large modern facility with extensive engineering controls, was built to 
produce TDI-based polyurethane foams for home furnishings and related uses. 
Demographic and workforce characteristics of the initial 49 workers who were hired and 
enrolled, the 37 workers remaining at one-year follow-up in the study, and the 12 workers 
lost to follow-up are summarized in Table I. No new employees were enrolled during this 
time period. At baseline, the workers were predominately male (69.4%), middle-aged 
(mean 39 years), smokers (40.8% current smokers), and none reported a past diagnosis of 
asthma. The potential risk of TDI exposure was estimated to be high for 13 subjects 
(26.5%) who worked in the foaming hall, medium for 28 subjects (57.1%) who worked in 
cutting, maintenance and laboratory areas, and low for the remaining 8 subjects (16.3%), 
based on job category. There were no significant differences in demographics or 
exposure risk group, comparing baseline, follow-up and lost to follow-up groups of 
workers. 
 
Exposure Assessment: 
 
Continuous fixed-point air sampling performed in the foaming hall and cutting areas over 
the 1-year study period showed that airborne TDI concentrations were low, below the 
limit of detection (LOD) of 0.1 ppb in over 87% of the air recordings obtained in the 
20 
 
 
 
cutting areas and over 95% of the readings from the foaming hall. Over the entire 12-
month study period, the maximum TDI vapor concentration recorded was 10.0 ppb in the 
foaming hall and 5.4 ppb in the cutting area, and no air sampling period exceeded the 
threshold limit value (TLV) for a 8-hr workday assigned by the American Conference of 
Governmental Industrial Hygienists (ACGIH) for TDI (0.005 ppm; 36 ug NCO/m3), the 
occupational exposure limit used in the United Kingdom, and many European countries
16
. 
The brief peak exposures recorded were also well below the Permissible Exposure Limit 
(PEL) ceiling for TDI (0.020 ppm) set by the Occupational Safety and Health 
Administration (OSHA)
16
. 
 
Representative TDI air sample data from the cutting area for a 6-week period between 
November and December 2010 is shown in Figure 1. While most levels are below the 
LOD (0.1 ppb), brief intermittent TDI exposures were noted, the majority of these below 
5 ppb. A 6-day period within the 6-week period shows several peak exposures in the 
cutting area on production days between 10 am and 2 pm (peak production time periods) 
and non-detectable airborne TDI levels during non-production hours (e.g. weekends). 
Consistent with the fixed-point air sample monitoring, the limited personal quantitative 
air sampling performed on 7 different workers in the foaming hall and cutting area all 
showed TDI levels below the LOD. 
 
The potential for TDI skin exposure was evaluated using TDI qualitative SWYPE™ 
sampling of selected environmental surfaces in the plant and worker questionnaires. 
Eleven surfaces in the cutting room and foaming hall, including tables, handrails, 
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machinery, and foam were sampled. Three of the 11 (27.2%) surface SWYPE™ samples 
were positive, including two SWYPE™ samples taken of the paper lining that had been 
peeled from the cured polyurethane foam at the end of the line, before cutting the foam. 
Additionally the hands of one worker who had just cleaned the foaming head sampled 
positive for TDI using the SWYPE™ wipes. Based on the questionnaire data, thirteen 
workers (28.2%) reported potential TDI skin contact (e.g. from handling freshly cured 
product or recently used machine part). 
 
Workers Lost to Follow-up: 
 
Twelve of the initial 49 workers (24.5%) in this inception cohort were no longer available 
for follow-up by the end of their first 12-months of employment, as shown in Tables I 
and II. Six of the 49 workers (20.4%) were no longer working at the plant at the time of 
follow-up, one of whom was reported as being "sick" at 6-month follow-up, 4 workers 
were “unavailable” during follow-up, and two workers refused subsequent participation. 
There were no differences in demographics or exposure risk group, comparing the lost to 
follow-up group to the other workers. 
 
Asthma Symptoms: 
 
The symptom data at baseline, 6 and 12-month follow-up is summarized in Table II, 
including the available data on the 12 workers lost to follow-up during this 1 year follow-
up period. The overall prevalence of symptoms was low, and similar comparing baseline 
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and the 2 follow-up times. However, a significantly higher proportion of workers lost to 
follow-up (3/12; 25%) reported current asthma-like symptoms, compared to those who 
remained working and enrolled in the study (1/37; 2.7%) (p=0.04). However, considering 
only those workers who were lost to follow-up and had left the company compared to 
those who were reportedly still employed, 16.7% (1/6) who left the company had 
reported current asthma symptoms compared to 7.0% (3/43) who were still employed. 
The only worker who reported new asthma symptoms that were work-related had 
resigned and left the workplace. Three workers reported new asthma-like symptoms over 
the 12 months (7.1%), including the worker noted above, who reported a relationship 
between his symptoms and work (at 6 months) and at 12 months was lost to follow-up (as 
noted above). 
 
Isocyanate Serology: 
 
Serum TDI-specific IgG and IgE results are shown in Table II, with no significant 
differences noted between the groups of workers. Of note, one worker, a maintenance 
worker with prior occupational TDI exposure, exhibited an elevated TDI-specific IgG 
(titer 1:160) pre-employment, which was then negative at 6 and 12 months after 
employment at this new plant. Another worker developed a positive TDI-IgG (titer 1:40) 
between employment and the 6-month follow-up, which then resolved by 12 months, 
during which time the worker had been transferred to a low exposure job. All TDI-
specific IgE tests were negative at 6 months, and not tested at the other time points due to 
sample limitations. 
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Spirometry: 
 
The results of spirometry testing at baseline, 6 months and 12 months follow-up are 
shown in Table I. Spirometry was obtained on all workers not lost to follow-up at 6 and 
12 months. However, due to logistical issues, spirometry was available on only 24 of the 
49 (49 %) workers at baseline, and the baseline testing was performed at a different site 
than the follow-up testing. There were no significant differences in FEV1, FVC and 
FEV1/FVC comparing baseline, follow-up and the workers lost to follow-up, or when 
comparing only those workers with spirometry data at all 3 time points (N=16). Of note, 
no workers had airflow obstruction (FEV1/FVC < LLN) at baseline, 1 worker (2.4%) had 
airflow obstruction at 6 months (initial test for that worker) and 2 workers (5.4%) had 
airflow obstruction at 12 months, one of whom had new onset airflow obstruction (1/37; 
2.7%). Additionally, a decrease in FEV1 of > 15% was noted in 3 workers (9.1%) 
between baseline and 12 months, one of whom reported new asthma symptoms. 
 
Relationships with Exposure Risk: 
 
The relationships between exposure risk groups, health outcomes, reported skin exposure 
and loss to follow-up were explored (Table III). No significant associations were 
observed between the assigned exposure risk group, based on job category, and new 
asthma-like symptoms, new eye irritation, baseline lung function, change in lung function 
over the year of follow-up, or workers lost to follow-up. Self-reported glove use differed 
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significantly between workers in the different exposure risk groups. All 13/13 workers 
(100%) of the high exposure risk group reported glove use, while only 8/25 workers 
(32.0%) in the medium risk group used gloves. The potential for skin exposure, reported 
by 28.3% of the workers, was similar in all exposure groups. 
 
Workers with Possible Early TDI-Related Health Effects: 
 
Although the company reported no known cases of isocyanate-related allergy or asthma, 
over the first year of follow-up 7 of the 49 original workers (14.2%) developed either 
new asthma symptoms (N=3), a positive TDI-IgG (N=1), new airflow obstruction (N=1) 
or a decline in FEV1 > 15% (N=3), findings that could indicate TDI-related health effects. 
For example, one worker, a laboratory chemist, developed a 1:40 titer of TDI-IgG and 
new-onset eye irritation during the first 6 months of employment, after which she 
changed to a low exposure risk job, and at the 12 month follow-up evaluation both had 
resolved. A second worker, from the cutting area, reported new asthma-like symptoms 
that were work related at 6 months and was then lost to follow-up at the 1-year follow-up. 
A third worker, from the warehouse (low exposure risk), developed new asthma-like 
symptoms by 6 months, and exhibited a greater than >20% decrease in FEV1 between 6 
and 12 months post-employment. Together the findings in these workers suggest possible 
increased risk for isocyanate sensitization and asthma, despite very low measured 
airborne TDI exposures. More thorough medical evaluation of selected workers, such as 
bronchodilator testing or peak flow monitoring, was not possible. 
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DISCUSSION: 
 
To our knowledge this is the first longitudinal inception cohort study of polyurethane 
foam production workers in a modern facility designed to minimize airborne TDI 
exposures, despite the expanding use of polyurethane in numerous industries and types of 
manufacturing. Data were obtained during the initial year of the modern new factory’s 
operation, with longitudinal evaluation of workers pre-employment, and at 6-month 
intervals post-employment. Measured airborne TDI levels were very low, well below 
PELs for TDI established by advisory and/or regulatory agencies. 
 
Over the first year of follow-up, 12 of the initial 49 workers (24.5%) were lost to follow-
up and 7 workers (14.2%) developed findings that could indicate TDI-related health 
effects. These findings highlight the potential risks of isocyanate exposure, even at very 
low levels, and the need for further epidemiology studies, ideally longitudinal inception 
cohort studies. 
 
Several findings from this 1-year longitudinal follow-up of an inception cohort of 
polyurethane foam production workers are notable. First, almost 25% of the initial 
inception cohort of workers was lost to follow-up over the first year. A priori, we 
expected excellent follow-up of the initial workers, given local economic considerations, 
the modern facilities, government-mandated medical surveillance of workers, and the 
established relationship between members of the investigative team and the plant. The 
large proportion of workers lost to follow up, while unexpected, is consistent with other 
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longitudinal studies of isocyanate exposed cohorts, where up to 50% (or more) of the 
workers were lost to follow-up
17-20
, or where follow-up was not clearly detailed
21,22
. 
 
A second notable finding from this study was the potential for exposure to TDI, despite 
the modern facilities and intensive industrial hygiene efforts, including ventilation, 
automated, enclosed production machinery, and continuous real-time monitoring of 
airborne concentrations. Although most area air sample measurements were below the 
limit of detection, and never exceeded OSHA’s ceiling PEL, or the more conservative 
TLV recommended by the ACGIH and similar European advisory councils (see above), 
TDI vapor levels from 0.5 to 5 ppb were commonly measured during peak foam 
production hours (10 AM - 2 PM). Furthermore, intermittent low level spikes in TDI air 
levels occurred in both the foaming hall, where workers expect potential exposure and 
wear protective equipment, and the cutting area, where exposure is not expected and 
workers rarely wear protective equipment. 
 
The overall prevalence of asthma symptoms and/or immunologic sensitization to TDI 
was low among workers that completed their first year of employment at this modern 
TDI polyurethane production facility. However, 14.2% of the original workers developed 
findings suggestive of possible TDI-related health effects (new asthma symptoms, TDI-
specific IgG, new airflow obstruction, and/or a decline in FEV1 > 15%). These findings 
should be considered in the context of (the lack of) available diagnostic tests for 
isocyanate sensitization and asthma, as well as uncertainty regarding the natural history 
of disease. While isocyanate asthma has been reported to occur within weeks to months 
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of exposure, the latency period between onset of exposure, immune sensitization, and 
asthma symptoms may vary and has been difficult to define
4,10,18,23
. With continuing 
improvements in industrial hygiene and reduction of airborne TDI levels, the latency 
period, if it occurs, may be further increased. More long-term follow-up of the current 
cohort, while challenging, is needed, as well as further evaluation of those with findings 
suggestive of possible isocyanate asthma, to better understand the risks of isocyanate 
exposures, and to assess whether current work controls are effective at preventing 
isocyanate sensitization and asthma. 
 
This study data also demonstrated potential TDI skin exposure of the workers, based on 
limited SWYPE™ qualitative testing and questionnaire data, which may represent 
another exposure route (besides respiratory) capable of inducing systemic immune 
sensitization. Notably, TDI was detected on surfaces that workers may touch when not 
wearing gloves (such as handrails, table) and 28.2% of all workers reported potential TDI 
skin contact by questionnaire. Site visits during the study documented extensive use of 
respiratory and skin PPE in the foaming room during production, but more limited use of 
PPE in the cutting room (occasional gloves), consistent with the questionnaire data. Also 
noted was unprotected hand contact with uncured or just cured polyurethane during 
cleaning of the “foaming head”, where the positive skin and surface SWYPE™ samples 
were detected, and contact with just cured foam emerging from the production oven.  
 
Based on the findings of the study, several recommendations have been made to further 
protect the workers from exposure to isocyanates. Although careful, conscious design of 
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the facilities has been implemented to limit airborne exposures, measures to protect 
workers against skin exposure are suggested. Further testing should be performed with 
greater sensitivity to ensure that the polyurethane foam is safe to handle when it is cut. 
Additionally, gloves that are impervious to both isocyanates and other potential co-
exposures should be provided and enforced for workers cleaning the foaming head due to 
potentially significant exposure to isocyanates. 
 
Several limitations of the study should be recognized, mainly related to limited size of the 
cohort, the limited follow-up time period, and the suboptimal spirometry. The size of the 
inception cohort was constrained by the company's production plans and an automated 
manufacturing process. As noted above, the 1-year follow-up duration limits insight into 
the prevalence of TDI sensitization and asthma, which can take longer than 1 year to 
develop, and almost 25% of the initial inception cohort was lost to follow-up. The 
reason(s) workers resigned, refused, or were not present was not generally available. 
Efforts are on-going to follow-up these workers. Further medical evaluation of the 7 
workers with findings suggestive of possible isocyanate asthma could help clarify risk, 
but was not feasible. Unfortunately baseline spirometry was obtained on less than half of 
the workers and at a different facility, and the full spirometry data was not available, 
limiting quality assessment and analysis. These considerations were taken into account in 
interpreting the findings. 
 
Another limitation of the study was the limited TDI air and skin exposure assessment and 
the job-based assignment to exposure risk groups, which may have misclassified some 
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workers. Airborne TDI levels were based almost exclusively upon fixed area samples, 
which may not accurately reflect individual exposures, especially during selected tasks 
such as cleaning and maintenance, and localized TDI air levels may have been higher 
near the source. Methods for quantifying isocyanate skin exposure remain experimental; 
thus, the present investigation relied upon questionnaire data and qualitative approaches 
of assessment. The relatively small sample size and low prevalence of symptoms, TDI-
IgG and other outcomes limited statistical power to compare workers in the different 
exposure risk groups. Limited funding also prohibited more extensive quantitative 
exposure assessment. 
 
In summary, the present investigation describes a unique inception cohort from a new 
modern polyurethane foam factory with very low measured airborne TDI levels. Twelve 
of the initial 49 workers (24.5%) were lost to follow-up in the first year. These workers 
were significantly more likely to report current asthma symptoms, and also included the 
only worker with new asthma symptoms that were work-related, suggesting a possible 
healthy worker effect. Among the 37 workers that completed the study, 7 workers either 
developed respiratory symptoms, TDI-specific IgG and/or changes in spirometry that 
may represent early TDI-related health effects. Further longitudinal follow-up of the 
current workforce, including those lost to follow-up, as well as better exposure 
assessment, are needed to better characterize the risks of TDI exposure in modern 
polyurethane production facilities. 
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Table I. Demographic Characteristics and Workforce Exposure Risk Groups 
Characteristic 
Baseline 
N (% total) 
12 month 
N (% total) 
Workers lost to follow-up 
N (% total)
*
 
Total workers 49 (100) 37 (100) 12 (100) 
Gender    
Male 34 (69.4) 26 (70.3) 8 (66.6) 
Female 15 (30.6) 11 (29.7) 4 (33.3) 
Age (years)    
Mean ± SD 39.1 ± 11.6 40.6 ± 11.8 37.8 ± 11.5 
Range 20-59 21-59 24-59 
Smoker    
Current 20 (40.8) 15 (40.5) 5 (41.7) 
Former 8 (16.3) 6 (16.2) 2 (16.7) 
Never 21 (42.9) 16 (43.2) 5 (41.7) 
Diagnosed asthma    
Yes 0 (0.0) 0 (0.0) 0 (0.0) 
Job risk group    
Low
a 
8 (16.3) 8 (21.6) 2 (16.7) 
Medium
b 
28 (57.1) 18 (48.6) 8 (66.7) 
High
c 
13 (26.5) 11 (29.7) 2 (16.7) 
N=number of workers/total number of workers for which data were available (%) 
*
Six workers were no longer working at the plant, 4 were not present, and 2 refused to participate. 
a
Administrative/quality and engineer/fire guard workers 
b
Cutting/laboratory/maintenance workers 
c
Foaming hall workers 
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Table II. Questionnaire, Spirometry, and Serology Data at Baseline and Follow-up 
 Baseline
*
  
N=49 
6 month
*
  
N=42 
12 month
* 
N=37  
Lost to Follow-up
**
 
N=12 
Overall symptoms n (%)     
Current asthma symptoms  3/49 (6.1) 3/42
a
 (7.1) 1/37 (2.7) 3/12 (25.0)
e
 
New asthma symptoms N/A 3/42 (7.1) 0/37 (0.0) 1/9 (11.1) 
New eye irritation N/A 1/42 (2.4) 1/37 (2.7) 0/9 (0.0) 
Spirometry     
FEV1 L (mean + SD); % 
pred (mean + SD) 
3.27 + 0.75  
88.0 + 12.0 
3.77 + 0.76 
98.0 + 13.0 
3.88 + 0.99 
99.0 + 15.0 
3.72 + 0.85 
99.0 + 14.0 
FVC L (mean + SD); % 
pred (mean + SD)  
4.02 + 0.90 
86.0 + 11.0 
4.48 + 0.85 
94.0 + 13.0 
4.55 + 1.08 
94.0 + 14.0 
4.46 + 1.04 
95.0 + 15.0 
FEV1 / FVC (mean + SD)  0.82 + 0.08 0.84 + 0.07 0.85 + 0.09 0.84 + 0.04 
FEV1/FVC < LLN  (n, %) 0/23 (0.0) 1/42 (2.4) 2/37 (5.4) 0/9 (0.0) 
Decline in FEV1  > 15% 
(n, %) 
N/A 0/19 (0.0) 3/33 (9.1) 0/3 (0.0) 
ELISA     
TDI IgG positive 1/48
b
 (2.1) 1/39
c
 (2.6) 0/37 (0.0) 0/11 (0.0) 
TDI IgE positive NT
d
 0/39 (0.0) NT 0/12 (0.0) 
*
Number of workers/total number of workers for which data were available (%) 
**
Of the 12 subjects lost to follow-up, 10 were no longer at work at the plant, 4 were not present and 2 refused to 
participate. 
a
One worker reported work-related asthma symptoms at 6 month follow-up. 
b
One worker with TDI-IgG at baseline tested negative in the follow-up period. 
c
Another worker with negative IgG at baseline developed positive IgG at 6-month follow-up. 
d
NT=Not tested 
e
A higher percentage of subjects lost to follow-up (25%) reported current asthma conditions than those that were not lost to 
follow-up (2.7%) (p=0.04).  Fisher’s exact test was utilized to test for association (categorical outcomes).  Analysis of 
variance was used to test for differences in means for continuous outcomes. 
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Table III. Comparison Across Workforce Exposure Risk Groups Over 1 Year Follow-Up 
Period 
 All* 
N=49 
Low risk* 
N=8 
Medium risk* 
N=28 
High risk* 
N=13 
New asthma 
symptoms 
3/46 (6.5) 1/8 (12.5) 2/25 (8.0) 0/13 (0.0) 
 
New eye irritation 2/42 (4.8) 0/8 (0.0) 2/22 (9.1) 0/12 (0.0) 
New airflow 
obstruction: 
(FEV1/FVC < LLN) 
1/40 (2.5) 1/6 (16.7) 0/22 (0.0) 1/12 (0.0) 
 
Decline in 
FEV1 >15% 
3/40 (7.5) 1/6 (16.7) 2/22 (9.1) 0/12 (0.0) 
 
Gloves worn** 25/46 (54.3) 4/8 (50.0) 8/25 (32.0) 13/13 (100.0) 
Self-reported skin 
exposure 
13/46 (28.3) 2/8 (25.0) 8/25 (32.0) 3/13 (23.1) 
 
Workers lost to 
follow-up 
12/49 (24.5) 2/8 (25.0) 8/28 (28.6) 2/13 (15.4) 
 
*Number of workers / total number in each category (% total) 
** p < 0.05 comparing the exposure risk groups. Fisher’s exact test was performed to generate p values. 
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FIGURE LEGENDS: 
 
Figure 1. Airborne TDI levels for representative 6-week period. Y-axis depicts TDI 
concentration in parts per billion, over time (X-axis). Each spike represents one 18 
minute long period of measurement. Representative data from the cutting room are 
shown for a 6-week period (Nov-Dec 2010). Long dashes are weekdays and stars 
represent weekends. Boxed area is enlarged in Figure 2. 
 
Figure 2. Airborne TDI levels for representative 6-day period. Y-axis depicts TDI 
concentration in parts per billion, over time (X-axis). Area measurements for the 6-day 
period (indicated in Fig. 1) highlight typical patterns of daily fluctuation. 
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